INSIGHTS ON DRUG DEVELOPMENT
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and deārisk innovative programs through early dialogue.
-
Engineering The Future Of Lipsomal Drug Delivery
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
Facts About AAV Producer Cell Lines
Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.
-
Characterizing mRNA Using Ion-Pairing Reversed-Phase LC/MS
mRNA poly(A) tail analysis depends on targeted digestion, clean LC/MS conditions, and reliable deconvolution. See how RNase 4 digestion and optimized ion-pairing methods support reproducible results.
-
Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products9/9/2026
A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.
-
The Delicate Dance: When Phase-Appropriate Decisions Carry More Risk9/23/2026
Early drug development demands speed, but some decisions carry long-term consequences. Learn which process and analytical choices require teams to look beyond the next milestone.
-
Complete Your Journey To Therapeutic Success8/17/2026
Explore integrated workflows for peptide identification, impurity analysis, sequence confirmation, and characterization, supported by advanced technology and expert guidance to improve productivity.
-
Streamline Drug Development With A Lab Informatics Platform8/13/2025
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.
-
Easy Automation For Cell-Based Assays10/10/2025
Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.
DRUG DEVELOPMENT SOLUTIONS
-
With high-performance optics and ergonomic design, the Leica DM IL LED is ideal for cell culture, micromanipulation, documentation of immunostained specimens, and routine live cell examinations.
The Leica DM IL LED features a comprehensive set of contrast methods to monitor your specimen the way you need. High-quality Phase contrast, excellent modulation contrast and brilliant fluorescence are just one fingertip away. Robust stability, plenty of space to work with tools, long working distances to accommodate large culture flasks and a stable illumination without heat make work at the microscope easy and convenient.
For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) including in-vitro-fertilization (IVF).
-
Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers such as CAS numbers, structural features, and typical marketed dosage forms.
-
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.
-
Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.
-
Power. Potential. Productivity.
STELLARIS 5 is a completely re-imagined confocal microscope platform.
STELLARIS confocal microscopes can be combined with all Leica modalities, including FLIM, STED, DLS, and CRS. With the STELLARIS confocal platform, we have re-imagined confocal microscopy to get you closer to the truth.
- Power to see more
- Potential to discover more
- Productivity to do more